BofA Says Halma Valuation Does Not Reflect Stronger Growth, Margins Amid Broad-based Strength

MT Newswires · 1d ago
08:12 AM EST, 11/20/2026 (MT Newswires) -- BofA Global Research said Halma's (HLMA.L) current valuation does not reflect its stronger growth and margins as the British health and safety device maker's recent results highlight broad-based growth and profitability. "Halma trades at c.17x EV/EBITA FY2, a c.25% discount to its 10-year average of 23x. We see this as unjustified given structurally higher profitability, with operating margins c.270bps above the 10-year average, alongside a strong growth outlook," the research firm said in a Friday note. Halma's fiscal first-half revenue grew 12.3% on an organic basis, 80 basis points higher than consensus, despite lower-than-anticipated growth at the company's photonics business. "Strength was broad-based, with c.10% organic growth in Safety, c.12% growth in E&A excluding photonics and MSD growth in Healthcare. Adj. EBIT margin reached 24.1%, above Halma's 19-23% through-cycle target, supported by volume, mix and accretive M&A/divestments. We increasingly see the current margin range as outdated, with M&A and operating leverage having structurally lifted profitability," analysts said. "Management remains confident on 2H27 growth and margins given healthy customer demand, while expecting to offset upcoming cost inflation through pricing." Against this backdrop, BofA lifted its adjusted EBITA estimate by 2% for fiscal 2027, while reducing its EPS forecasts for fiscal years 2027 through 2029. The buy rating on the stock was maintained, with a price objective of 46 pounds sterling.